THE D MAJOR GROUP for EMD SERONO, INC.
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Monitor accelerated approval and other FDA-related provisions as included in HR 2167, the "Consolidated Appropriations Act for FY2023."
| Lobbyist | Covered position, as disclosed |
|---|---|
| DIANE MAJOR | Health Policy Analyst for Senate Repub. Policy Com't. |
| BRENDA REESE | Conference Coordinator for House Republican Conf. |
Defense DEF
Monitor DOD Tricare coverage of fertility treatments for active duty personnel.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DIANE MAJOR | Health Policy Analyst for Senate Repub.Policy Com't. |
| BRENDA REESE | Conference Coordinator for House Repub. Conference |
Copyright/Patent/Trademark CPT
Monitor issues concerning "march-in" rights as related to pharmaceutical research and development.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DIANE MAJOR | Health Policy Analyst for Senate Republican Policy Committee |
| BRENDA REESE | Conference Coordinator for House Republican Conference |
Medicare/Medicaid MMM
Monitor the impact of HR 5376, the "Inflation Reduction Act," on pharmaceutical research and development -- specifically, provisions affecting women's health, oncology and immunotherapy discoveries.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DIANE MAJOR | Health Policy Analyst for Senate Republican Policy Committee |
| BRENDA REESE | Conference Coordinator for House Republican Conference |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.